GlycoMimetics (NASDAQ:GLYC) Earns Overweight Rating from Analysts at Cantor Fitzgerald
Cantor Fitzgerald started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research note published on Friday, MarketBeat reports. The brokerage issued an overweight rating on the biotechnology company’s stock. Separately, StockNews.com initiated coverage on shares of GlycoMimetics in a research note on Friday, March 14th. They issued a “sell” rating for the […]
Cantor Fitzgerald started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research note published on Friday, MarketBeat reports. The brokerage issued an overweight rating on the biotechnology company’s stock. Separately, StockNews.com initiated coverage on shares of GlycoMimetics in a research note on Friday, March 14th. They issued a “sell” rating for the […]
